Technology
Health
2016 IPO

MYOS RENS

2,437

$1.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+4.73%) Today
+$0.04 (+2.78%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MYOS RENS and other stocks, options, ETFs, and crypto commission-free!

About MYOS

MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. Read More The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.

CEO
Joseph Manello
Employees
15
Headquarters
Cedar Knolls, New Jersey
Founded
2007
Market Cap
17.06M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
23.69M
High Today
$1.65
Low Today
$1.41
Open Price
$1.50
Volume
1.95M
52 Week High
$3.85
52 Week Low
$0.7412

Collections

Technology
Health
2016 IPO
US
North America

MYOS News

BenzingaJul 1

Why Shares of Myos Rens Are Spiking Higher

Shares of nutrition company MYOS Corporation (NASDAQ: MYOS) were more than doubling Wednesday. The Myos Reverse Merger: Myos announced late Tuesday that it has
0

MYOS Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 4, After Hours

You May Also Like

CMSD
CHIX
PFF
STIM
SMED
BUI
SPSM
KDMN
PTF
BMI
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MYOS

Market Price$1.48
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MYOS RENS stock and options commission-free.
LearnBlogCareersHelpLog InSign Up